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Structure-Activity Relations: Maximizing
the Usefulness of Mutagenicity and
Carcinogenicity Databases
by G. Klopman* and H. Rosenkranzt
Themostimportantcriteriaforthedevelopmentandanalysisofdatabasesforelucidating thestructuralbasesoftox-
icological activity include theintegrity ofthedatabases withrespect touniformity oftheexperimental protocoland in-
terpretationofthetestresultsandinclusionofch clsrepresentin differentchemicalclasssanddifferingmechanisms
ofaction. Within thesecriteria, itisde_mostrated thatwhenthechemialsarechosenatrandom, thelarerthedatabase,
thebetterthepedictvityofchemialsnotinlud inthelearning sL Itisshownhower,thatwhenchemicasare selected
onthebasisofstructuralfeatures, thatalearningsetofapproxmately 180chemicals isasinformativeasadatabasecon-
sisting of800chemicals chosenat random.
Introduction
Whereas mostcurrentstudies, includingthosereportedinthis
symposium, deal with theclassification ofinformation, our ap-
proach is to rationalize the available data and thus permit ex-
trapolation to molecules that have as yet not been tested. The
eventual outcomeofsuch anapproachistohelpoptimize ongo-
ingstudies suchthatthey, inturn, willprovide a maximal amount
ofinformation ofa mechanistic and predictive nature.
Acharacteristic oftheavailabledatabasesofdirect concernto
usisthatthey arecomposedofawidevarietyofchemicals with
diverse structures, e.g., polycyclic aromatic hydrocarbons,
nitrosamines, halogenated hydrocarbons, and dyes. They are
thus notamenable to traditional quantitative structure-activity
relationship (QSAR)-type studies, which require congeneric
databases. To overcomethisobstacle, wehavebeeninvestigating
how knowledge-based systems could be useful.
Inthis survey wediscuss ourexperience withusingavailable
databasesofcarcinogenic, mutagenic, andrelatedbiological end
points toestablish such a resourceundertaken formechanistic as
well as predictive purposes. We stress that our analysis is, of
course, influencedby thestructure-activity relationship (SAR)
methodology weemploy, namely, CASE(1,2). Howvver, CASE,
as anartificial intelligence/expert system, isprobably oneofthe
most advanced SAR methods available and a harbinger ofthe
developments that are to come to this methodology ingeneral.
In this connection, it is germane to list some of the unique
features that were incorporated into this program:
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1. Inordertomakethe systemtruly effective, ithadtobein-
dependent of operator-formulated questions. These by
definition, arefiniteandsimplisticandusuallybasedupon
previousknowledge (i.e., they maybebiased). Thus, we
requiredthesystemtogenerateallofthepossiblestructural
"descriptors" automatically withoutoperatorinput.
2. Becausewefeltthatthebiologicalactivityisdependenton
molecularsubunitsusually largerandmorecomplexthan
thoseconsideredbychemistsassimplefunctionalities, we
requiredthatoursystembecapableofhandlingandiden-
tifyingrelatively large molecularmoieties.
3. We realized that most SAR systems are based on the
analysis ofcongeneric databases. e.g., nitroarenes, aro-
matic amines, halogenated hydrocarbons, etc. This,
however, involvesthearbitraryassignmentofchemicalsto
certainclassesand, whendealingwithdatabases contain-
ingvariouschemicalclasses, mighta)intrducebiasinthe
selection process and b) make the emerging classes too
small for adequate structural analysis. Moreover, if
biological activity is derived inherently from structural
features, by "artificially" separating chemicals into
restrictedclasses, wemightloseinformationalcontent. Ac-
cordingly, weneeded a systemthatwas abletohandle, in
a single database, molecules ofvery different chemical
types.
4. Wealso wanted to include in our system thecapability of
updating the "descriptors" as information on new
molecules became available, i.e., the system had to be
self-learning.
5. Werequiredtheresultinganalysesnotonlytobepredictive
but also to provide clues as to possible mechanisms of
biological activity.
6. Finally, we wanted the system to handle biological end
points that may result from a single mechanism, a com-KLOPMANAND ROSENKRANZ
binationofconcertedorsequentialactions, ortwoormore
independentmechanisms.
The program we constructed to meet these requirements is
called CASE and, in its latest and greatly improved version,
MULTICASE.
Nature ofthe Database
Whataresomeofourconclusionsrelatingtotherequirements
ofthe composition ofa database tobeuseful for SAR studies?
Becauseofthegrowing sophisticationofcomputer-based SAR
systemsandtheinvestmentoftimeaswellasCPUcost, itisim-
portanttobeginwithcarefullyevaluateddatabases. Someofthe
requirementsforsuchdatabasesareself-evident: Thedatabase
mustbeobtained using standardprotocols forwhichthequali-
tyofthedatamustbemonitored. Thisisborneoutbyexperience
with someofthecytogenetic endpointsthatarecontainedinthe
Gene-ToxProgramdatabaseascomparedtothoseintheNational
Toxicology Program (NTP)compilations. Thus, evenusingthe
peer-review processinherentintheGene-ToxProgram, theSAR
methodologycouldnotbeappliedwithgreatsuccesstosomeof
theGene-Toxdatabases (unpublished results), whereastheNTP
databases allowedthoroughanalysesofthestructuralfeaturesof
thecytogenetic activities(3). Ouranalysis ofthedataled us to
conclude that the difference came from the quality control,
which was assured in the NTP protocol but could not be con-
trolled intheGene-ToxProgram. This isduetothefactthatthe
latterreliedonpublisheddata, and, moreover, thechemicalpuri-
ty (orratherimpurity) was notgenerally known. Nevertheless,
CASE can handle some "fuzziness" in the data because it is
basedonthestatisticalevaluationoftheimportanceofsubstruc-
ture rather than on aquantitative relation.
The second, alsoperhaps self-evident, pointrelates tothein-
terpretation ofthedata. Boththebiological and statistical stan-
dards used for interpreting the test results must be adhered to
rigidly and must, of course, be spelled out initially. This is
especiallyimportantinthemannerinwhichresultsareexpressed
when a continuous activity scale is used, e.g., revertants per
nanomole ormilligrams per kilogram perday. Although there
arecomputer routines toscaleandmodelcutoffs, thisjudgment
should notbedelegated to acomputer. In fact, wefindthatthe
humanexpertisessentialtodeterminetheboundarybetweenin-
active andmarginally active chemicals andbetweenmarginal-
lyactiveandactivechemicals. Thescaling canthenbedoneby
the computerfollowing these initial boundary settings.
In addition to defining the accepted definitions of the end
pointswithrespecttodatabases, thepurposeoftheanalysismust
alsobedefinedaprioi. Thus, fordifferentmechanisticpurposes
wemightusedifferentmutagenicity databases ordifferentcol-
lectionsofdataderived fromthesecompilations. Forexample,
a) mutagenicity in a specific Salmonella tester strain in the
absence ofS9 might be used. The purpose ofsuch an analysis
wouldbeperhapstostudythestructuralbasisofthemutagenicity
ofnitrated polycyclic aromatic hydrocarbons, which are max-
imally expressed in strain TA98 in the absence ofexogenous
metabolicactivation(1,4).b)TheactivitymightbeinSalmonella
TAIOO orinTA98 inthepresenceofS9. Thus, forthearomatic
amines, thiswouldallowthedeterminationofspecific combina-
tionsthatwouldbeinformative. Infact,usingadatabaseofonly
TA100 inthepresenceofS9 as againstoneofonlyTA98 inthe
presence ofS9, theeffectofmutagenic specificityby aromatic
amines at a single guanine-cytosine (G-C) base pair (as in
TA100)asopposedtothespecificityataseriesofalternatingG-C
pairs (asinTA98)wasamenabletoanalysis(5,6). c)Ontheother
hand, ifwe wish to study and evaluate how Salmonella muta-
genicitycomparesinitspredictivitytotheresultsofrodentcar-
cinogenicity bioassays, then for the Salmonella data we might
defineas apositive responsearesponse inany oneofthetester
strains obtained either in the presence or absenceofS9 (2,7).
Under these conditions, ofcourse, it must be ascertained that
beforeachemicalisdesignatedasnegativethatithasindeedbeen
testedinthecompletepaneloftesterstrainsbothinthepresence
andabsenceofS9. Obviously, thisapproach, whichhasalsobeen
usedto assess thepredictivity ofthe Salmonella assay for car-
cinogenicity inrodents(810), assumesthatthestructuraldeter-
minantsresponsible foractivityindifferentstrainsareidentical
andequallyrelatedtocarcinogenicity. Infact, weknowthatthese
areoversimplifications.
NatureoftheChemicalsintheDatabase
Thenatureofthechemicalsrepresentedinthedatabaseisprob-
ablythemostdifficulttoaddress.InviewofthefactthatCASEcan
handlenoncongenericdatabases,thensomeoftherequirements
areeasytostatebutdifficulttoimplement: Adatabase(i.e.,learn-
ingset)shouldcontainrepresentativesofvariouschemicalclasses
andchemicalsthatcoverthespectrumofmechanismsthatinduce
aparticularbiologicalendpoint(11). Tosatisfy sucharequire-
ment, it might seem a truism to say that a variety ofchemical
classesneedtoberepresentedinthedatabase. However, thisis
more easily said than done. Looking at the problem from a
chemicalpointofview,using,forexample,theexperienceofthe
Gene-ToxProgram,initially,inexcessof60chemicalclasseswere
defined(12). This resulted in a situation that for SAR studies,
therewereveryfewrepresentativesperchemicalclasssuchthat
SAR analyses were not feasible. Subsequently, the number of
chemical classes was reduced to 30 (13). Still, this left many
chemical classes underrepresented for the purpose of SAR
analysis. Moreover, suchseparationsimplythatweknowthose
structural featuresthatarenecessaryforbiologicalactivity. This,
ofcourse, involves aselectionbias. Ontheotherhand, asystem
likeCASEselectsitsowndescriptors, andtheseinturnallowit
tobypass thetraditional chemical classes (Table 1).
It is ofinterest that by and large the CASE program usually
identifies not more than approximately 12 to 15 significant
biophores in a noncongeneric database (Table 2). This means
that there are usually a sufficient number of representative
chemicalsineachofthebiophoreclassesthatareselected. Ad-
ditionally, CASE also identifiesbiophobes, i.e., functionalities
thatcontribute to alackofactivity. Thesemightbe considered
as "non-alerts" inthe schemeofAshby (14).
In creatingdatabases, ifone has unlimited funds, one might
decidetotestasmanychemicalsaspossibleandentertheresults
intothedatabase. Undersuchconditions, oneneednotbecon-
cerned about redundancy of chemical structures. Thus, one
would notbeworried thatthere mightbetoo many nitrofurans
inadatabase, asthelogicoftheCASEprogramseestoitthatthe
biophore associated with nitrofurans will achieve significance
whenacertainpresetprobability valuehasbeen reached (e.g.,
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Table 1. Molecules sharing a common biophore.5
CH =CH
CH
-C.
CH"
o-Phenanthroline
D & C Yellow 11
9-Nitroanthracene
l-Nitro-2-methylnaphthalene
C.I. Pigment Red 3
C.I. Pigment Red 23
D & C Red 9
8-Hydroxyquinoline
C.I. Solvent Yellow 14
N-Phenyl-2-naphthylamine
Benzo(a)pyrene
3-Methylcholanthrene
Benz(a)anthracene
7,12-Dimethylbenz(a)anthracene
Phenanthrene
Benzo(J)quinoline (beta-Na)
l-Nitronaphthalene
Naphthalene
Quinoline
2-Naphthylamine
Coumarin
Anthracene
Pyrene
l-Naphthylamine
Benzo(e)pyrene
1,8,9-Trihydroxyanthracene
1-Naphthylisothiocyanate
2-Anthramine
7,9-Dimethylbenz(c)acridine
N-(l-Naphthyl)ethylenediam
7-Bromomethyl-12-methylbenz(a)anthracene
aNote thatpolycyclic aromatic hydrocarbons, aromatic amines, nitroarenes,
and others contain this biophore, which has been identified as significant with
respect to mutagenicity in Salmonella (p = 0.0001).
Thble2. Smeofthebiophoresandbiophobescontributingtotheprobability
ofcarcinogenicity inrodents.'
Numberof Marginally
Fragment fragments Inactive active Active Probability
Activatingb
NH2-C= 53 12 5 36 0.000
Cl-CH2- 19 5 2 12 0.058
C"-O-C= 5 0 0 5 0.031
O-CH2-CH- 6 0 1 5 0.031
C=CH-C=C- 49 11 6 32 0.001
CH=C-C=CH- 54 14 7 33 0.005
CH=C*-CO-C*= 5 0 0 5 0.031
CH2-CH2-CH2-CH- 5 0 0 5 0.031
O-CO-C=CH- 9 0 3 6 0.020
Inactivating
OH-CH- 9 8 1 0 0.004
S-CH- 5 4 1 0 0.063
aThis table lists the distribution ofthe majorfragments amongactive, inac-
tive, and marginally active molecules. This distribution is used topredict the
likelihood that the presence (or absence) ofthe fragment contributes to car-
cinogenicity. Alsolistedaretheprobability valuesassociatedwiththefragments.
bC-indicates acarbonatomcommontotworings. C "indicatesthecarbonis
attached by adouble bond to anoutside substituent.
p < 0.05), atwhichpointthatbiophorewillbeflaggedandiden-
tified. Having more representative molecules containing that
biophoreinthepool will notcontributeoverwhelmingly tothe
predictivity. Similarly, usingthe samereasoning, ifthedatabase
contains toogreat aprevalenceofactivemolecules, thiswill not
affect the identification and performance of the predictive
biophoresthat areidentifiedprovidedthatthere are asufficient
numberofmolecules in thedatabase.
Congeneric versus Noncongeneric
Databases
HeretoforethemajorityofSARmetfiodsweredesignedforthe
studyandpredictionofcongenericdatabasessuchasthosecon-
tainingpolycyclicaromatichydrocarbons, nitroarenes, aromatic
amines, etc. Oneofthebreakthroughsprovidedby CASEis its
ability to analyze none congeneric databases (i.e., mixed
databases). Thequestionthenfacingusis: Everything elsebe-
ing equal, how do the two types of databases compare with
respecttopredictivity?
Letustakethe NTPCarcinogen Database as anexample. In
one ofour analyses we had approximately 250 chemicals, of
which53 werearomaticamines(15,16)(Table3). Asanexercise,
wethen selectedthe53 aromaticaminesandusedthemtocon-
structacongenericdatabase. Wethenusedthetwodatabases, the
noncongenericandthecongenericonetostudythepredictivity
ofeach ofthem for aromatic amines. The results indicate that
bothdatabaseswerehighlypredictiveofthecarcinogenicity of
aromatic amines (Table4). However, furtheranalysisindicated
thatthenoncongeneric database wassignificantly morepredic-
tivethanthecongenericone. Thisappearstobederivedfromthe
factthatthebiophoresselectedbyCASEmaycutacrosschemical
speciesandcould, forexample, havebeenderivedinthecaseof
thenoncongenericdatabasenotonlyfromaromaticaminesbut
possiblyfromrelatednitroarenes. Inthecaseofthecongeneric
database consisting only ofaromatic amines, such biophores
would not necessarily be identified (Table 5). Thus, the non-
congenericdatabasemayindeedbesuperiorevenwhenasuffi-
cient number of congeneric database chemicals are present
thereinbecauseCASEcanlearnfromrelatedmoleculeswhich,
forexample,mayyieldthesamemetabolicintermediates (e.g.,
N-arylhydroxylamines), whicharederivedfrombotharylamines
and nitroarenes by oxidative and reductive pathways, re-
spectively.
Table3. Relationship between structureofaromatic aminesand
carcinogenicity inrodents.
% Actives
andequi-
Fragment Total Inactive Equivocal Active vocals
All molecules 252 88 29 135 65.1
NH2-C= 53 12 5 36 77.4
NH2-C=CH-CH=' 38 10 5 24 76.3
NH2-C=C-CH=CH-b 19 3 0 16 84.2
NH2-C=CH-CH=
C-C-NH2b 4 0 0 4 100
'This fragment is not associated with an increased probability ofcarcino-
genicity.
bCASE identifiedthesearomaticamine-derived fragments asassociated with
an increasedprobability ofcarcinogenicity.
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Table 4. Comparison ofcongeneric versus noncongeneric database inthe
prediction ofthecarcinogenicity ofaromatic amines.
Noncongeneric' Aromatic amines
Number 252 53
Carcinogens 65.1% 77.4%
Correct predictions 96.2% 88.7%
Expected (random) predictions 56.4% 56.4%
X2 44.22 29.04
'Contains the53 aromatic amines.
R R
I I
TbbIe5. Somenonaromaticamin thatsharebiophoresCH=C-C=CH-
witharomatic amines.'
Mutagenicity
Chemical Carcinogenicityb (Salmonella)
CI. Disperse Yellow 3 A +
HCBlue1 A +
Nitrofen A +
D&CRed9 B +
3,3'-Dimethoxybenzidine-4,4'-
diisocyanate B +
2,4-Dinitrotoluene B +
3-Nitro-p-acetophenetide D +
HC Blue 2 NC +
Tetrachlorvinphos A
'R is nota hydrogen. This biophore was identified inthe total database con-
sistingof253 chemicals. Itwas notfoundtohavesignificanceinthedatabasecon-
sisting only ofaromatic amines.
bClassifications ofAshby and Tennant (9). A, induces tumors in rats and
mice; B,carcinogenic toonly onespeciesbutinduces cancers attw ormoresites;
D, carcinogenic ata single site in a single species; NC, noncarcinogenic.
How ManyChemicals Are Needed
in a Database?
Obviously, we do not possess unlimited resources, and the
number ofchemicals thatcanbetested isby necessity limited.
Therefore, wemightaskthequestion, howmanychemicalsare
needed in the learning set when it consists ofnoncongeneric
molecules? This is a question that needs to be decided when
testingprogramsaresetupandthedatausedforSARanalyses.
InTable6weshowthepredictivityofusingdifferentnumbers
ofchemicals inthelearning set. The chemicals inthelearning
set were selected at random from the NTP Salmonella Mu-
tagenicity Database. Thebiophoresidentifiedusingthedifferent
databases werethenusedtopredictthemutagenicity ofapanel
of 100chemicals, not inthelearning set, but for which the test
results wereavailable ("diagnostic tester set").
Theresultsoftheanalysisclearly showthatthepredictiveper-
formanceofCASE improves withanincreaseinthenumberof
chemicals in the learning set (Table 6). However, generating
databasesconsistingofsuchlargenumbersofchemicalsiscostly,
even if we restrict the testing to the Salmonella mutagenicity
assay only. Obviously, ifwe use experimental systems thatare
morelaborintensiveorwhichinvolvelargenumbersofanimals,
thecostwillrapidlybecomeprohibitive. Thus, itisnotsurprising
thatvery fewrodentcancerbioassayshavebeenrepeatedgiven
acostwhichmay exceed$1 million perassay.
In search for amethodtodecrease the numberofchemicals
thatrequiretesting(i.e., tolimitthesizeofthedatabase), weex-
plored a number ofpossibilities. We devised an efficient pro-
cedure, whichisdependentonanotherfeatureofCASE. Indeed,
CASEpredictionscantakeanumberofforms: a)achemicalcan
Tbhle6.Predictive oda asesco incrasingnumbers
ofrandomlyselectedchemicals.'
n Concordance, % X2
25 60.2 5.89
50 58.9 3.78
100 68.2 14.67
243 75.3 27.4
820 81.0 31.3
'All ofthe subsets ofchemicals are contained within the set of 820. The
chemicalswerechosenatrandomfromamongthe820moleculesinthedatabase
exceptforthe243chemicals, alsoasubsetofthe 820thatrepresentschemicals
onwhich rodent cancerbioassays wereperformed (9,10).
FIGURE 1. CASE prediction of the mutagenicity in Salmonella of 1,3-di-
methyl-4-nitrobenzene.
bepredictedtobeactivebecauseitcontains abiophore(Fig. 1);
b) achemical canbepredictedtobeinactivebecauseitcontains
abiophobe (Fig. 2); c) amolecule canbepredicted tobe inac-
tivebecauseitlacks arecognizablebiophoreand/orbiophobe.
Thatlaterpredictionisduetothefactthatfragmentationofthe
molecule yields fragments that had been seen before but had
beenjudgedtobetrivialwithrespecttobiologicalactivity(Fig.
3); d) an additional possibility is that the CASE program has
identified anunrecognizedfunctionality (i.e., unknown). This
referstothepresenceofafragmentthathasnotbeendocumented
among the collection offragments generated (Figs. 4-6). The
presenceofsuch afragmentintroduces a noteofinconclusive-
ness into theprediction, which appears to be the major reason
for decreased predictive performance (17). This uncertainty
might, in fact, be a direct function ofthe numberofchemicals
inthelearning set. Thatis, the morechemicals there are inthe
learning set, the less the chance that this message will appear
(Table7).
Can SAR Concepts Reducethe
NumberofChemicals That Need to
Be Tested to Generate a Useful
Database?
Asshownabove, thelargerthedatabase, thebetterthepredic-
tiveperformance. However, thequestionthenstillis are wereal-
ly interestedingenerating, at agreatcost, databasesthatallow
85, 90, 99, or even99.9% concordances between experimen-
tal results andpredictions, especially iftheactualexperimental
data areonly 85% reproducible, as appears to bethe situation
with the NTP Salmonella Mutagenicity Database? In fact, a
numberofanalyses haveindicated thatthe limit ofthepredic-
tivity ofthe CASE program formutagenicity in Salmonella is
1,3-Dimethyl-4-nitrobenzene
93%chanceofbeingACTIVEduetosubstructure(Conf. level= 100%):
N02-C=CH-CH=
80%chanceofbeingACTIVEduetosubstructure(Conf.level =87%):
N02-C=C-CH=
* **OVERALL,theprobabilityofbeingaSalmonellamutagen is98.2%*
* *
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approximately 80% (17). Moreover, thereproducibilityofthero-
dentcarcinogenicity bioassayislargelyunknownsincesofewof
thechemicalshavebeentestedmorethanonce. Weoughttoaim
for economy andreliability.
FIGURE 2. CASEprediction ofthe lackofmutagenicity ofbenzyl violet4B.
FIGURE 3. CASE prediction of the lack of mutagenicity of tert-butylhy-
droquinone. Fragmentationofthismoleculedoesnotyieldfragmentsthathave
been identified as biophores ofbiophobes.
FIGURE 4. CASE prediction ofthe mutagenicity of2-aminobenzimidazole.
CASErecognized abiophorethatleadstoan87% probability ofmutagenicity.
However, this conclusion mustbemoderated by the factthatthismolecule
containsafragmentthathasnotbeenseenbeforeandthatcouldbeabiophobe.
FIGURE 5. CASE prediction ofthe lackofmutagenicity ofcysteine due tothe
presence ofabiophobe. However, this conclusion ismoderated by the fact
thatcysteinecortains afragment not seenbefore, whichmightbe abiophore.
FIGURE 6. A CASE prediction of lack of mutagenicity due to the fact that
fragmentation ofthe molecule does not lead to the generation ofeither a
biophoreorabiophobe. However, thispredictionmustbemoderatedbythe
factthatafragment, heretoforenotseen, hasbeenrecognized, anditcould
beabiophore.
Table 7. Effect ofsize of the learning set on the number of inconclusive
predictions.'
Numberofchemicals Inconclusive
inlearning set predictions, %b
25 61
50 54
100 47
250 33
820 22
aThediagnostic testersetconsistedof100moleculesthatwerenotpresentin
thelearning sets.
bNumberofpredictions inthediagnostictesterthatcontainfragmentsthathad
notbeenseenbefore(seeFigs. 4-6)andwhichthereforemaybeinconclusive.
Our analysis of the performance of CASE suggests that
perhaps we could use the uncertainty factor (see above) in the
designofadatabasethatwillcontainthefewestchemicals that
needtobetested. Totestthishypothesis, thefollowingprotocol
wasdevisedandtested: a)alistofchemicalsincludingdifferent
chemicalclasses, differentuses, anddifferentlevelsofproduc-
tion(18)isselected; b)fromamongthislist, wemightselect, at
random, say 100chemicalsthatwillbetested(orwhichalready
mayhavebeentested). Thisformstheoriginallearning set(set
1); c) this original learning set is analyzed by CASE and the
biophoresandbiophobesareidentified;d)anothersetof50ran-
domly selectedchemicals (excludingthosechemicals in set 1),
asyetuntested, arerunagainstthisoriginallearningset; e)those
chemicalswhich, in stepd, yieldapredictionthatincludesthe
uncertainy messagearethenselectedfortesting asmutagensin
Salmonella. The results ofthe tests are then included in a new
learning set(set2, whichincludesthechemicalsinsetI);J)this
procedure isperformed iteratively.
Toevaluatetheeffectivenessoftheselectionprocedureateach
step, thepredictivityofthedatabaseisevaluatedbychallenging
itwiththehundredchemicalsnotincludedinthelearningsetsbut
forwhichtestresultsareavailable("diagnostictesterset"). The
resultsoftheseanalysesclearlyindicate (Table8)thatbycareful
selectionofchemicalsfortesting,thenumberofchemicalsthat
need to be tested to generate a learning set adequate for SAR
predictions can be greatly reduced. This is accompanied by a
correspondingdecreaseincost. Infact, acomparisonofTables
6 and 8 clearly indicates that a database ofapproximately 180
carefully selectedchemicals is aspredictive as adatabase con-
sistingofinexcessof800chemicalsthathavenotbeenselected
bythecriteria. Similarresultswereobtained(19)usingtheGene-
Benzyl Violet 4B
2-Ammino-4-(methylsulfonyl)phenol
***WARNING*** Thefollowingfunctionalities are UNKNOWN to me:
***SO2-C=CH-
** The results may be INCONCLUSIVEduetothe presenceof
UNKNOWN functionalities **
**No basis found to support activity; The molecule is presumed
INACTIVE** 66% chanceofbeing INACTIVE duetosubstructure (Conf. level=97%):
CH=C-C=C-
***downgraded from 86% because of incorrect Conformation
75% chanceofbeing INACTIVEduetosubstructure(Conf. level=75%):
CH2-N-C= <2-CH2>
83% chance ofbeing INACrIVE duetosubstructure (Conf. level=94%):
CH=C-CH= <S-SO2>
***OVERALL, the probability of being aSalmonella mutagen is3.4%***
tert-Butylhydroquinone
**No basis found to support activity; The molecule is presumed
INACTIVE**
2-Aminobenzimidazole
***WARNING*** Thefollowing functionalitiesare UNKNOWN to me:
*** NH2-C"'-NH-
** The results may be INCONCLUSIVE duetothe presenceof
UNKNOWN functionalities **
87%chanceofbeingACrIVEduetosubstructure(Conf. level=100%)
CH=CH-CH=CH-C-=
***OVERALL,theprobabilityofbeingaSalmonella mutagen is87.0%***
CYSTEINE
***WARNING*** Thefollowing functionalities are UNKNOWN to me:
*** SH-CH2-CH-
** The results maybe INCONCLUSIVE duetothe presenceof
unknown functionalities **
83%chance ofbeing INACTIVE duetosubstructure(Conf. level=94%):
CO-CH-NH2
***OVERALL, theprobabilityofbeingaSalmonella mutagen is 17.0%***
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lible8 Predictive performanceofdatabasecontainingincreasingnumbers
ofselectedchemicals.
Set n Concordance, % X2
1 lOOa 69.3 6.36
2 119 77.0 19.75
3 142 77.6 21.89
4 160 74.0 16.59
5 179 80.8 28.11
6 198 78.0 22.76
7 210 80.6 26.77
8 219 78.1 22.59
'The first 100chemicals arepresumed to represent a randomassortment of
molecules. Theywerenotselectedbytheproceduredescribedhere. Eachsubse-
quentsetcontainsanincrementofmolecules selectedfromsetsof50. Thus, set
2containstheprevious 100molecules (set 1)plus 19selectedfromamongaset
of 50. Similarly, set 3 contains the previous 119 moleclues (set 2) plus 23
molecules selected from among another set of 50. This procedure is used
iteratively. The selection ofmolecules is described inthetext.
ToxSalmonelladatabase, whichnotonlycontainsadifferentcol-
lection ofchemicals but also a higher prevalence ofmutagens
(78.5% versus 36.5%).
Quantitativeversus Binary Databases
There are two major ways ofexpressing the results ofSAR
analyses: a) as active, marginally active, and inactive. This, a
priori, involves aprejudgmentinvolving thehumanexpertwho
then sets the boundaries as to what is considered a positive,
marginal, and negative result. Summarizing the results in this
mannerandapplyingtheCASEprogramleadstothegeneration
of fragments that are involved in the probability of a certain
biological activity (e.g., mutagenicity, carcinogenicity) and
thereforeprovides apossibleprocedureforriskidentificationfor
testing prioritization. Indeed, such probabilities appear to be
relatedtothebiologicalproperties. Thus, thedegreeofthecar-
cinogenicityofachemicalasdefinedbyAshbyandTennant(9)
appears to be related to the probability ofcarcinogenicity: an
overallhighprobability isassociated withchemicalsthatcause
cancerinbothratsandmiceatmultiplesitesofbothsexes(Table
9). b)When,however, resultsareexpressedinacontinuousscale
(e.g., TD50inmilligramsperkilogramperdayormutagenicity
in revertants per nanomole), this permits two independent
analysestobecarriedout: aprobabilityofcarcinogenicity, iden-
tical to the procedure described above and a QSAR analysis,
which leads to the identification ofbiophores and biophobes
associated with potency (Table 10). Thelatteranalysis leads to
a secondprediction, thatofpotency (Fig. 7).
Thus, fromthefragmentsassociatedwiththemutagenicpoten-
cy ofnitroarenes (Table 10), we cancalculatetheprojected ac-
tivity ofachemical where
CASEactivity = 9.208 + nF + 1.22 logP
where n is the number of times a fragment occurs in the
molecule, FistheCASEactivityassociatedwiththatfragment
(Table 10), andPisthen-octanol/waterpartitioncoefficient. Ac-
cordingly, for 1,6-dinitropyrene (Fig. 7), biophore B (which is
present twice) is the same as biophore 7 (Table 10), which is
associated with a mutagenic potency of 21.576 units, and,
moreover, 1,6dinitropyrenealsocontainstwocopiesofbiophore
3 (17,093 units) (Table 10).
Table9. Relationship betweentheprobability ofcarcinogenicity
andcarcinogenic classification.
Rodents Rats Mice
Group' n Probability n Probability n Probability
A 64 75.0 ± 14.0
B 19 73.9 ± 14.2 50 66.3 ± 11.0 46 67.2 ± 17.3
C 27 67.9 ± 16.9 21 59.6 ± 15.3 34 65.3 ± 10.9
D 25 70.8 ± 12.9 29 63.2 ± 17.7 19 62.3 ± 16.7
E 29 45.0 ± 30.9 18 7.4 ± 18.8 17 18.7 ± 27.1
NC 88 74.8 ± 13.1 134 9.0 ± 17.6 136 8.1 ± 14.8
A + B 83 74.8 ± 14.1 50 66.3 ± 11.0 46 67.2 ± 17.3
C + D 52 69.1 ± 11.6 50 61.7 16.8 53 64.3 13.3
All 252 51.2 ± 30.2 252 30.7 ± 31.7 252 34.1 ± 32.6
aThe classification ofAshbyand Tennant (9) wasadopted. In that scheme,
chemicalsingroupAinducetumorsinratsandmice. GroupBincludeschemicals
thatarecarcinogenictoonlyonespeciesbutwhichincludecancersattwoormore
sites. GroupCconsistsofchemicalsthat arecarcinogenic atonly a single site
inboth sexesofasingle species. Group Dcontains chemicals carcinogenic at
asinglesiteinasinglespecies.GroupEisadequatelystudiedchemicalsforwhich
onlyequivocalevidenceofcarcinogenicity wasobserved. NC,noncarcinogens.
Table 10. Some biophobesassociated withthe mutagenic
potency ofnitroarenes.'
Numberof
QSAR fragments chemicals QSAR
N02-C=CH-C-= 45 11.382+++ 1
CH=C--C=CH- <3-NO> 3 17.093+ 2
CH=C--C=CH- <3-NO2> 49 17.093+++ 3
OH-N-C=CH- <3-CH=> 1 5.390 4
NO-C=CH-CH=C-- 3 21.576+ 5
NO2-C=CH-CH=C- 15 8.754+++ 6
NO2-C=CH-CH=C-- 57 21.576+++ 7
CH=C-C=CH-C= <3-NO2> 10 3.982+++ 8
NO2-C=C-CH=CH-C= 10 3.982+++ 9
CH=CH-C=CH-C=C- <5-NO2> 10 3.982+++ 10
N02-C=CH-C=CH-CH=C- 10 3.982+++
'Constant = 9.208.
[1,Dinitropyrene
FIGURE 7. Prediction of the mutagenicity and mutagenic potency of 1,6-
dinitropyrene.
AnotherfeatureofCASEistheestimationofthelogP, which
for 1,6-dinitropyrene is 4.7968. Accordingly, the CASE activi-
ty of 1,6-dinitropyrene is
9.208 + [2(17.093)] + [2(21.576)] + 4.7968 = 92
CASE activity is expressed in a log scale; an activity of92 is
equivalent to 200,000 revertants/nmole. This, in fact, goes
beyond mereriskidentification, whichisbased ontheprobabili-
ty ofactivity, becausethepredictionalsoinvolves a measureof
potency that canbeused in aquantitative risk assessment. Ob-
(A) 97% chance of beingACTIVE due tosubstructure(Conf.
level =100%): CH=CH-C =C-CH=CH-C=
(B)95% chanceofbeing ACTIVE dueto substructure (Conf.
level = 100%): NO2-C=CH-CH=C-
(C) 92% chanceof beingACTIVE dueto substructure (Conf.
level = 100%): CH=C C:-CH-
***OVERALL, the probability of being a Salmonella mutagen is 100%' * *
**Thecompound ispredictedtobe EXTREMELYactive(92) * *
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FIGURE 8. Relationship betweenexperimental andpredicted mutagenic ac-
tivity foraseriesofnitroarenes. Theactivities areexpressedinCASEactiv-
ity units, which is a logarithmic scale; r2 = 0.8371.
viously, before using such potency values, they mustbe com-
paredagainst the experimentally obtained values (Fig. 8).
In addition to allowing an estimation of the potency of an
unknownchemical,theidentificationofthebiophoresassociated
with potency permits anassessmentofthe relative role ofdif-
ferentbiophores inactivity. Thus, asaresultofthelogarithmic
natureoftheactivity scale, itcanbecalculated thatbiophore 7
(Table 10) contributes 88% ofthemutagenicityof1,6-dinitro-
pyrene; i.e, itisthemajorcontributortopotency. Suchanalyses
haveobviousmechanistic implications (20). Thus, studies seek-
ing to investigate the basis ofthe potent mutagenicity ofthis
chemical shouldconcentrate on thatportion ofthe molecule.
Comparison ofSomeCarcinogenicity
Databases
Wehaveperformedanalysesofanumberofdifferentrodent
carcinogenicity databases including the NTP rodent bioassay
(9,10) and the compilation of Gold and associates (21-23)
which includesTD50values. Analyzingthesedatabases allow-
ed us toidentify the structural features responsible forthe pro-
bability of carcinogenicity (i.e., the qualitative aspect of the
analysis). Moreover, byanalyzingcarcinogenicity foronly the
mouse or only the rat, we were able to identify biophores
characteristic for each ofthese activities as well as biophores
commontoboththeratandthe mouse. Thesehavemechanistic
implications that will notbe described here (see below).
ApplyingtheQSARCASEanalysistothedatabaseassembled
by Gold etal. (21-23), which includesTD50 values, indicated
thatthedatacouldbeused to generateQSARrelationships for
individualdatabases (i.e., mouseand ratseparately) which, in
turn, canbeused toprojectcarcinogenicpotenciesbased upon
theQSARcontributionofindividualbiophores (Table 11). [The
TD50 value is defined as the lifetime dose (milligrams per
kilogram perday) thatreducesby one-halfthe lifetimechance
ofremainingtumor-free (24). Thus, carcinogenic potency can
be projected in a manner similar to that described for the
mutagenicity of 1,6-dinitropyrene (see above).
Validation
Beforeusingthebiophoresandbiophobes forpredictiveand
mechanisticstudies, anumberofcontrolsneedtobeperformed.
Routinely, fromtheavailabledatabase, asetofrandomlyselected
chemicalsisremovedbeforetheCASEanalysis. Thesechemicals
arethenusedas atestersettotestthepredictivityofthedataset.
Subsequently, ofcourse,thesechemicals canbeaddedbacktothe
learning setandtheCASEanalysisperformedagain.
Additionally, when analyzing biological activities such as
mutagenicity, cytogenotoxicity, and carcinogenicity, we also
assembled a database of naturally occurring physiological
chemicals (amino acids, sugars, lipids, purines, pyrimidines,
vitamins, etc.). These chemicals are expected to be negative.
However, onoccasion, wehavefoundthat somedatabases led
to predictions that a significant fraction of physiological
chemicals induced someendpoints, e.g., sister chromatid ex-
change. Suchfindings castdoubt ontherelevanceofsuch assays
as predictors ofcarcinogenicity (25).
Data Management
Finally, adata management system mustbe inplace to keep
track ofthe various predictions that are made in the course of
theseanalyses. Additionally, thiswillenabletestingcorrelations
ofpredictions. Thus, such adatamanagement systempermitted
Table 11. Somebiophoresandbiophobes contributingto thecarcinogenic potency.a
QSAR fragmentsb Numberoffragments Inactive Marginally active Active QSAR
NH-CH- 5 4 1 0 -11.445--
OH-CH 9 8 1 0 -11.445---
S-CH- 5 4 1 0 -11.445--
Cl-CH= 4 0 0 4 19.531++
CI-CH2- 19 5 2 12 10.057++
C"-O-C= 5 0 0 5 30.867+++
C=CH-C=C- 49 11 6 32 6.387+++
CH=C--CO-C-= 5 0 0 5 8.502+++
NH2-C=C-CH=CH- 19 3 0 16 22.936+ ++
Cl-C=C-CH=CH- 6 5 0 1 -13.869--
CH=CH-C=CH-CH= <3-N> 8 2 0 6 9.863+ +
CH=CH-CH=CH-C-=C-CH= 4 4 0 0 -19.938- -
aConstant = 23.818. The QSARactivity is used to calculate potency using the equations: QSAR activity = 23.818 + nfFfnb Fb where n denotes the number
biophore Ff orbiophobe Ff that ispresent inthe molecule.
bC. indicates a carbon atomcommontotwo rings. C
"indicatesthe carbon is attached by adoublebond to an outside substituent.
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Table 12. Expected distributions oftest resultsamonga populationof
random molecules.'
Assay system Positive responses, %
Rodent carcinogens 56
Mutagenicity inSalmonella 39
Chromosomal aberrations (CHOcells) 50
Sisterchromatid exchanges (CHOcells) 71
Rodent carcinogen and mutagenicity 39
Rodent carcinogenicity and sister chromatid 44
exchanges
Rodent carcinogenicity and chromosomal 33
aberrations
Sister chromatid exchanges and chromosomal 44
aberrations
'These distributions are based upon the analyses of approximately 1150
chemicals representing many sources and uses.
Table 13. Effect ofthe prevalence ofcarcinogens among molecules on the
resultsofshort-term tests: preditedpositiveresponses ofshort-term tests.
Proportionofcarcinogens among population ofmolecules
Assay 0% 10% 20% 45% 65% 100%
Salmonella 13.9% 17.3% 20.9% 27.5% 34.0% 44.2%
Sister chromatid 47.0% 49.4% 50.8% 56.6% 62.8% 68.5%
exchanges
Chromosomal 23.3% 25.7% 27.9% 35.3% 41.6% 50.5%
aberrations
ustodeterminehowoftencarcinogensarepredictedtobemuta-
gensorhowoftenSalmonellamutagensarepredictedalsotoin-
duce chromosomal aberrations (Table 12).
Suchadatabase canalsobeusefulforotherpurposes. Forex-
ample, itcouldbeused todetermine theeffectontheresultsof
short-termtestsofdifferentprevalencesofcarcinogens. This, in
turn, will influence the testing strategy used to detect car-
cinogens. Such ananalysis shows (Table 13)thatthere isacon-
siderableproportionoffalsepositive results tobeexpected, as
evidencedbythefactthatwhentheprevalenceofcarcinogensis
0%, we can expect 14 and 47% of the chemicals to respond
positively intheSalmonellamutagenicity and sisterchromatid
assays, respectively (Table 13). Moreover, anunacceptably high
rateoffalsenegatives istobeexpectedaswell, forapopulation
ofonly carcinogens (100% prevalence) isexpected toyieldon-
lya44% rateofpositiveresponsesintheSalmonellamutagenici-
ty assay.
Conclusion
Pbwerful computer-based expert systems to study SAR are
nowavailable. However, asillustratedhere,thesemethodologies
aregreatlydependentonthenatureandorganization ofdatabases.
Moreover, ithasbeendemonstrated thatdatabasesneednotbe
extensive forSARanalysis. Thusthepresentstudiesindicatethat
predictive toxicology is possible.
This investigation was supported by the National InstituteofEnvironmental
Health Sciences (ES04659) and the U.S. Environmental Protection Agency
(R815488).
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